249 related articles for article (PubMed ID: 1824297)
1. Role of cholecystokinin in postprandial and vagally stimulated duodenal and gallbladder motility in dogs.
Thor P; Laskiewcz J; Maczka M; Konturek SJ
J Physiol Pharmacol; 1991 Dec; 42(4):381-8. PubMed ID: 1824297
[TBL] [Abstract][Full Text] [Related]
2. Relationship between gallbladder bile concentration and motility in conscious dogs: role of cholecystokinin.
Muramatsu S; Sonobe K; Mizumoto A; Yamada T; Itoh Z
Peptides; 1997; 18(1):111-8. PubMed ID: 9114460
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.
Thor P; Laskiewicz J; Konturek P; Konturek SJ
Am J Physiol; 1988 Oct; 255(4 Pt 1):G498-504. PubMed ID: 3177646
[TBL] [Abstract][Full Text] [Related]
4. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
Romański KW
J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
[TBL] [Abstract][Full Text] [Related]
5. Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors in the vagal pathway and gallbladder in the dog.
Sonobe K; Sakai T; Satoh M; Haga N; Itoh Z
Regul Pept; 1995 Dec; 60(1):33-46. PubMed ID: 8747782
[TBL] [Abstract][Full Text] [Related]
6. [Neurohormonal regulation of gallbladder motility].
Pawlik TJ
Przegl Lek; 1994; 51(1):37-42. PubMed ID: 7911587
[TBL] [Abstract][Full Text] [Related]
7. [Regulative effect of leptin on gastric motility: experiment with conscious rats].
Wang LJ; Zhou L; Yuan B; Wang L
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2266-70. PubMed ID: 17064572
[TBL] [Abstract][Full Text] [Related]
8. Endogenous CCK is not involved in the regulation of interdigestive gastrointestinal and gallbladder motility in conscious dogs.
Mizumoto A; Ueki S; Ohtawa M; Itoh Z
Regul Pept; 1992 Oct; 41(3):249-56. PubMed ID: 1438992
[TBL] [Abstract][Full Text] [Related]
9. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
[TBL] [Abstract][Full Text] [Related]
10. Relation between duodenal alkaline secretion and motility in fasted and sham-fed dogs.
Konturek SJ; Thor P
Am J Physiol; 1986 Nov; 251(5 Pt 1):G591-6. PubMed ID: 3777166
[TBL] [Abstract][Full Text] [Related]
11. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
[TBL] [Abstract][Full Text] [Related]
12. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
[TBL] [Abstract][Full Text] [Related]
13. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z
Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by CCK of ascending contraction elicited by mucosal stimulation in the duodenum of the rat.
Giralt M; Vergara P
Neurogastroenterol Motil; 2000 Apr; 12(2):173-80. PubMed ID: 10877605
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and the interrelation between intestinal motility and pancreatic secretion in fasted and fed dogs.
Maczka M; Thor P; Bilski J; Konturek SJ
J Physiol Pharmacol; 1994 Jun; 45(2):285-98. PubMed ID: 7949237
[TBL] [Abstract][Full Text] [Related]
18. Ovine model for clear-cut study on the role of cholecystokinin in antral, small intestinal and gallbladder motility.
Romański KW
Pol J Pharmacol; 2004; 56(2):247-56. PubMed ID: 15156076
[TBL] [Abstract][Full Text] [Related]
19. [Cholecystokinin and its antagonists: effects on digestive motility].
Bruley des Varannes S; Cloarec D; Dubois A; Galmiche JP
Gastroenterol Clin Biol; 1991; 15(10):744-57. PubMed ID: 1816015
[No Abstract] [Full Text] [Related]
20. Neural mechanisms of pancreatic polypeptide release in conscious dogs.
Hosotani R; Chowdhury P; Huang YS; Rayford PL
Am J Physiol; 1989 Jul; 257(1 Pt 1):G134-7. PubMed ID: 2568754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
